Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$613K Sell
4,774
-1,307
-21% -$153K 0.18% 74
2026
Q1
$732K Hold
6,081
0.23% 69
2025
Q4
$640K Hold
6,081
0.2% 70
2025
Q3
$510K Sell
6,081
-2,460
-29% -$203K 0.16% 78
2025
Q2
$676K Hold
8,541
0.21% 76
2025
Q1
$767K Sell
8,541
-451
-5% -$42.1K 0.25% 70
2024
Q4
$895K Hold
8,992
0.27% 65
2024
Q3
$1.02M Buy
8,992
+38
+0.4% +$4.51K 0.31% 65
2024
Q2
$1.11M Buy
8,954
+38
+0.4% +$4.89K 0.36% 60
2024
Q1
$1.18M Buy
8,916
+41
+0.5% +$5.05K 0.38% 61
2023
Q4
$968K Sell
8,875
-511
-5% -$53K 0.33% 64
2023
Q3
$966K Sell
9,386
-5
-0.1% -$539 0.37% 62
2023
Q2
$1.08M Buy
9,391
+39
+0.4% +$4.43K 0.4% 57
2023
Q1
$995K Sell
9,352
-902
-9% -$97.4K 0.39% 62
2022
Q4
$1.14M Buy
+10,254
New +$1.05M 0.47% 57

Other funds holding MRK

Brady Family Wealth's MRK Position: Q2 2026 in Review

Brady Family Wealth reduced its Merck (MRK) stake by 21% in Q2 2026, selling an estimated $153K and leaving 4,774 shares worth $613K. The position accounts for 0.18% of the portfolio, ranked #74.

Brady Family Wealth first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.18M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Brady Family Wealth held 4,774 shares of Merck worth $613K as of Q2 2026.
  • Brady Family Wealth sold 1,307 Merck shares in Q2 2026, an estimated $153K.
  • Merck made up 0.18% of Brady Family Wealth's portfolio in Q2 2026, its #74 holding.
  • Brady Family Wealth first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Brady Family Wealth's Merck position peaked at $1.18M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Brady Family Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.